Clinical Related Factors Study Of Neonatal Hyperbilirubinemia

Objective: To investigate the related factors of neonatal hyperbilirubinemia(NHB), to provide clinical evidence for clinical prevention of neonatal hyperbilirubinemia.Method: Retrospective checking5023cases neonatal(normal newborn of4442casesand581cases of hyperbilirubinemia)had been enrolled from First Affiliated Hospital ofXinjiang Medical Obstetrics and neonatology from2011to2012.We analysis the relatedfactors using Logistic regression. Results:1. Binary Logistic regression analysis therelated factors showed: ethnicity, gestational age, birth weight for the the neonatalhyperbilirubinemia protective factors (P <0.05, β <0, respectively,-0.387,-0.446,-1.011,exp (β)<1, respectively0.473,0.246,0.016); premature rupture of membranes,cephalhematoma, method of feeding, mother and child blood group incompatibility, openmilk time compatriots in hyperbilirubinemia neonatal hyperbilirubinemia the redpigment hyperlipidemia risk factors (P <0.05,β>0,respectively,0.334,0.346,0.889,0.591,0.476,1.889, exp(β)>1,1.715,1.413,2.434,1.453,1.460,1.843). The neonatalhyperbilirubinemia as a research group, divided into the mild to moderate group, severegroup, the control group, a non-neonatal hyperbilirubinemia, multivariate logistic analysis:gestational age and birth weight the neonatal hyperbilirubinemia protective factors (P<0.05, β <0to-0.443,-1.011, exp (β) were <1, respectively0.441,0.016), mother andchild blood group incompatibility, open milk time, hyperbilirubinemia compatriots,premature rupture of membranes for their illness severity of risk factors (P <0.05, β>0,respectively1.673,1.361,1.657,0.452exp (β) were>1, were1.673,1.361,2.113,1.822);3.ethnic Uygur, Kazak neonatal hyperbilirubinemia low incidence (P <0.05), feedingpatterns, labor and mixed feeding than breastfeeding newborn hyperbilirubinemia The lowincidence of red pigment hyperlipidemia (P <0.05); Conclusion: Neonatalhyperbilirubinemia is a common disease of the newborn, a high incidence of activetreatment, according to the risk factors associated with the development of diagnosis and treatment programs, and a variety of related factors, actively prevent infection, emphasison prenatal inspection and after birth, bilirubin monitoring, reduce the incidence ofhyperbilirubinemia, particularly severe incidence of hyperbilirubinemia, reducing theimpact of hyperbilirubinemia neonatal growth and development.